Corgenix announces CE Mark notification for Lassa fever diagnostic test

Corgenix announces CE Mark notification for Lassa fever diagnostic test

DENVER-- Corgenix Medical Corporation (OTC BB: CONX), a global developer and marketer of diagnostic tests for cardiovascular disease, liver biomarkers and emerging pathogens and lethal viruses,... Read More

By: Steve Tuesday May 14, 2013 0 comments Tags: CE Mark, Corgenix, Denver, Douglass Simpson, Lassa fever